201 related articles for article (PubMed ID: 31857361)
1. Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan.
Marini I; Zlamal J; Faul C; Holzer U; Hammer S; Pelzl L; Bethge W; Althaus K; Bakchoul T
Haematologica; 2021 Jan; 106(1):196-207. PubMed ID: 31857361
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus.
Baroni Pietto MC; Lev PR; Glembotsky AC; Marín Oyarzún CP; Gomez G; Collado V; Pisoni C; Gomez RA; Grodzielski M; Gonzalez J; Mariño KV; Heller PG; Goette NP; Marta RF
Platelets; 2022 Jul; 33(5):743-754. PubMed ID: 34806522
[TBL] [Abstract][Full Text] [Related]
3. Immune attack on megakaryocytes in immune thrombocytopenia.
Petito E; Gresele P
Res Pract Thromb Haemost; 2024 Jan; 8(1):102345. PubMed ID: 38525349
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
Marini I; Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocyte modification of platelets in thrombocytopenia.
Roweth HG; Parvin S; Machlus KR
Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
7. Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver.
Ma X; Li Y; Kondo Y; Shi H; Han J; Jiang Y; Bai X; Archer-Hartmann SA; Azadi P; Ruan C; Fu J; Xia L
Haematologica; 2021 Mar; 106(3):759-769. PubMed ID: 32303557
[TBL] [Abstract][Full Text] [Related]
8. [TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA IN ADULTS: UPDATE].
Blickstein D
Harefuah; 2019 Mar; 158(3):196-199. PubMed ID: 30916510
[TBL] [Abstract][Full Text] [Related]
9. ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia.
Spindler M; van Eeuwijk JMM; Schurr Y; Nurden P; Nieswandt B; Stegner D; Reinhold A; Bender M
Blood; 2018 Aug; 132(6):635-646. PubMed ID: 29950291
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice.
Ouweneel AB; Hoekstra M; van der Wel EJ; Schaftenaar FH; Snip OSC; Hassan J; Korporaal SJA; Van Eck M
Atherosclerosis; 2019 Mar; 282():176-182. PubMed ID: 30278990
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid and platelet count regulation: Implications in immune thrombocytopenia.
Lee-Sundlov MM; Rivadeneyra L; Falet H; Hoffmeister KM
Res Pract Thromb Haemost; 2022 Mar; 6(3):e12691. PubMed ID: 35425875
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
13. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
[TBL] [Abstract][Full Text] [Related]
14. Inherited thrombocytopenia: novel insights into megakaryocyte maturation, proplatelet formation and platelet lifespan.
Johnson B; Fletcher SJ; Morgan NV
Platelets; 2016 Sep; 27(6):519-25. PubMed ID: 27025194
[TBL] [Abstract][Full Text] [Related]
15. Rasa3 deficiency minimally affects thrombopoiesis but promotes severe thrombocytopenia due to integrin-dependent platelet clearance.
Lee RH; Ghalloussi D; Harousseau GL; Kenny JP; Kramer PA; Proamer F; Nieswandt B; Flick MJ; Gachet C; Casari C; Eckly A; Bergmeier W
JCI Insight; 2022 Apr; 7(8):. PubMed ID: 35290242
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
18. New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia.
Althaus K; Faul C; Bakchoul T
Hamostaseologie; 2021 Aug; 41(4):275-282. PubMed ID: 33348391
[TBL] [Abstract][Full Text] [Related]
19. Immunofluorescence microphotometry for the detection of platelet antibodies. III. Demonstration of autoantibodies against platelets.
van Boxtel CJ; Oosterhof F; Engelfriet CP
Scand J Immunol; 1975; 4(7):657-72. PubMed ID: 1105766
[TBL] [Abstract][Full Text] [Related]
20. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
